Name | (S)-(+)-3-Chloro-1,2-propanediol |
Synonyms | Chloropropanediol S-3-chloro-1,2-propanediol (S)-(+)-ALPHA-CHLOROHYDRIN (S)-3-CHLOROPROPANE-1,2-DIOL (S)-3-chloro-1,2-propanediol (2S)-3-chloropropane-1,2-diol (S)-(+)-ALPHA-MONOCHLOROHYDRIN (S)-ALPHA-GLYCEROL CHLOROHYDRIN (S)-(+)-3-Chloro-1,2-propanediol (S)-(+)-3-CHLORO-1,2-PROPANEDIOL (S)-GLYCEROL ALPHA-MONOCHLOROHYDRIN (S)-(+)-GLYCEROL ALPHA-MONOCHLOROHYDRIN (S)-(+)-Glycerol alpha-monochlorohydrin |
CAS | 60827-45-4 |
EINECS | 612-041-7 |
InChI | InChI=1/C3H7ClO2/c4-1-3(6)2-5/h3,5-6H,1-2H2/t3-/m1/s1 |
InChIKey | SSZWWUDQMAHNAQ-GSVOUGTGSA-N |
Molecular Formula | C3H7ClO2 |
Molar Mass | 110.54 |
Density | 1.322g/mLat 25°C(lit.) |
Boling Point | 213°C(lit.) |
Flash Point | >230°F |
Water Solubility | Completely miscible in water |
Vapor Presure | 0.0374mmHg at 25°C |
Appearance | clear liquid |
Color | very deep yellow |
BRN | 2202929 |
pKa | 13.28±0.20(Predicted) |
Storage Condition | Inert atmosphere,Room Temperature |
Refractive Index | n20/D 1.480(lit.) |
Use | For the synthesis of Chiral reagents and pharmaceutical intermediates |
Hazard Symbols | T - Toxic |
Risk Codes | R21 - Harmful in contact with skin R25 - Toxic if swallowed R41 - Risk of serious damage to eyes R68 - Possible risk of irreversible effects R62 - Possible risk of impaired fertility R36/37/38 - Irritating to eyes, respiratory system and skin. R23/25 - Toxic by inhalation and if swallowed. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S28 - After contact with skin, wash immediately with plenty of soap-suds. S39 - Wear eye / face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
UN IDs | UN 2689 6.1/PG 3 |
WGK Germany | 3 |
RTECS | TY4202300 |
FLUKA BRAND F CODES | 3-10 |
HS Code | 29055900 |
Hazard Class | 6.1 |
Packing Group | III |
Use | Used to synthesize chiral reagents and pharmaceutical intermediates |